je.st
news
Home
› Icagen Issued U.S. Patent Covering Diagnostic And Discovery Applications Of Its Proprietary XRpro X-Ray Fluorescence Technology
Icagen Issued U.S. Patent Covering Diagnostic And Discovery Applications Of Its Proprietary XRpro X-Ray Fluorescence Technology
2016-06-01 06:00:52| drugdiscoveryonline Home Page
Icagen, Inc. recently announced that the U.S. Patent and Trademark Office has granted the company patent number 9,335,284 B2, “Methods for Analysis Using X-Ray Fluorescence,” covering applications of the company’s proprietary XRpro X-ray fluorescence technology to the development of biomarkers and diagnostics
Tags: technology
applications
issued
patent
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||